Orleans Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Orleans Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$313K	Buy	+5,436	New	+$312K	0.16%	102
2024 Q1	–	Sell	-14,721	Closed	-$755K	–	78
2023 Q4	$755K	Sell	14,721 -16,222	-52%	-$852K	0.51%	47
2023 Q3	$1.8M	Sell	30,943 -1,465	-5%	-$89.8K	1.33%	31
2023 Q2	$2.07M	Sell	32,408 -490	-1%	-$32.9K	1.47%	27
2023 Q1	$2.28M	Buy	32,898 +50	+0.2%	+$3.53K	1.68%	25
2022 Q4	$2.36M	Buy	32,848 +1,015	+3%	+$76.5K	1.81%	22
2022 Q3	$2.26M	Sell	31,833 -150	-0.5%	-$10.9K	1.89%	22
2022 Q2	$2.46M	Buy	31,983 +935	+3%	+$71.2K	1.84%	23
2022 Q1	$2.27M	Buy	31,048 +10,450	+51%	+$702K	1.41%	28
2021 Q4	$1.28M	Sell	20,598 -8,692	-30%	-$510K	0.73%	40
2021 Q3	$1.73M	Sell	29,290 -165	-0.6%	-$10.9K	1.11%	33
2021 Q2	$1.97M	Sell	29,455 -400	-1%	-$26.1K	1.26%	35
2021 Q1	$1.89M	Buy	29,855 +6,000	+25%	+$373K	1.28%	33
2020 Q4	$1.48M	Sell	23,855 -9,690	-29%	-$596K	1.06%	31
2020 Q3	$2.02M	Sell	33,545 -150	-0.4%	-$9.03K	1.54%	29
2020 Q2	$1.98M	Buy	+33,695	New	+$2.02M	1.62%	25
2014 Q4	–	Sell	-4,650	Closed	-$238K	–	93
2014 Q3	$238K	Sell	4,650 -83,819	-95%	-$4.19M	0.12%	92
2014 Q2	$4.29M	Buy	88,469 +1,140	+1%	+$56.2K	2.01%	8
2014 Q1	$4.54M	Sell	87,329 -1,296	-1%	-$69K	2.31%	5
2013 Q4	$4.71M	Sell	88,625 -877	-1%	-$44.7K	2.44%	3
2013 Q3	$4.14M	Sell	89,502 -8,447	-9%	-$371K	2.25%	3
2013 Q2	$4.38M	Buy	+97,949	New	+$4.25M	2.47%	3

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Orleans Capital Management's BMY Position: Q2 2026 in Review

Orleans Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 5,436 shares worth $313K. The stake represents 0.16% of the portfolio and ranks #102 among its holdings. This is a return to the name: Orleans Capital Management previously reported a position in BMY as recently as Q4 2023.

Orleans Capital Management first reported a position in BMY in Q2 2013 and has held it in 22 quarters since. The position peaked at $4.71M in Q4 2013. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Orleans Capital Management held 5,436 shares of Bristol-Myers Squibb worth $313K as of Q2 2026.
Bristol-Myers Squibb was a new Orleans Capital Management position in Q2 2026.
Bristol-Myers Squibb made up 0.16% of Orleans Capital Management's portfolio in Q2 2026, its #102 holding.
Orleans Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 22 quarters since.
Orleans Capital Management's Bristol-Myers Squibb position peaked at $4.71M in Q4 2013.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Orleans Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.